1 – 26 of 26
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Evaluation of the European Society of Cardiology/European Respiratory Society derived three-and four-strata risk stratification models in pulmonary arterial hypertension : Introducing an internet-based risk stratification calculator
(
- Contribution to journal › Article
-
Mark
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
(
- Contribution to journal › Article
- 2022
-
Mark
Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery
(
- Contribution to journal › Article
-
Mark
3D visualization of vascular lesions and the role of versican in pulmonary arterial hypertension
2022) In und University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
(
- Contribution to journal › Article
- 2021
-
Mark
Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Right heart structure, geometry and function assessed by echocardiography in 6-Year-old children born extremely preterm-a population-based cohort study
(
- Contribution to journal › Article
-
Mark
Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Distinct types of plexiform lesions identified by synchrotron-based phase-contrast micro-CT
(
- Contribution to journal › Article
-
Mark
Plasma tumour and metabolism related biomarkers AMBP, LPL and Glyoxalase I differentiate heart failure with preserved ejection fraction with pulmonary hypertension from pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2020
-
Mark
Plasma biomarkers in pulmonary arterial hypertension diagnosis, treatment response and risk stratification - utilizing Lund Cardio Pulmonary Register
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
(
- Contribution to journal › Article
- 2019
-
Mark
Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
(
- Contribution to journal › Article
-
Mark
Development and Validation of a Questionnaire to Measure Patient's Experiences of Health Care in Pulmonary Arterial Hypertension Outpatient Clinics
(
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2018
-
Mark
Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
(
- Contribution to journal › Article
-
Mark
Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
(
- Contribution to journal › Article
- 2017
-
Mark
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977-2012
(
- Contribution to journal › Article
-
Mark
Past and current cause-specific mortality in Eisenmenger syndrome
(
- Contribution to journal › Article
- 2016
-
Mark
Versican accumulates in vascular lesions in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2014
-
Mark
Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2005
-
Mark
Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001.
(
- Contribution to journal › Article